| dc.contributor.advisor | Mehtap, Özgür | |
| dc.contributor.author | Arvas, Hayati | |
| dc.date.accessioned | 2022-03-04T11:33:03Z | |
| dc.date.available | 2022-03-04T11:33:03Z | |
| dc.date.issued | 2019 | |
| dc.identifier.other | 538717 | |
| dc.identifier.uri | http://dspace.kocaeli.edu.tr:8080/xmlui/handle/11493/13350 | |
| dc.language.iso | tur | |
| dc.publisher | Kocaeli Üniversitesi, Tıp Fakültesi | |
| dc.rights | openAccess | |
| dc.subject | Lenfoma-büyük B-hücreli-yaygın | |
| dc.subject | Lymphoma-large B-cell-diffuse | |
| dc.subject | Nüks | |
| dc.subject | Recurrence | |
| dc.subject | Retrospektif çalışmalar | |
| dc.subject | Retrospective studies | |
| dc.subject | Sağkalım | |
| dc.subject | Survival | |
| dc.subject | Tedavi | |
| dc.subject | Treatment | |
| dc.subject | İlaç tedavisi | |
| dc.subject | Drug therapy | |
| dc.subject | İlaç tedavisi-kombine | |
| dc.subject | Drug therapy-combination | |
| dc.title | Nüks ve refrakter diffüz büyük B hücreli lenfoma hastalarının kurtarma tedavisine yanıtları ve sağkalımları | |
| dc.title.alternative | The response rates and overall survival status of relapsed and refractory diffuse large B cell lymphoma patients after salvage chemotherapy | |
| dc.type | specialtyThesis | |
| dc.contributor.department | İç Hastalıkları Ana Bilim Dalı | |
| dc.identifier.endpage | 52 |